Is sucralose safe? EFSA's 2026 assessment of E955

Sucralose is an intense sweetener also identified as E955. In 2026, EFSA confirmed safety for currently authorised uses but could not confirm the safety of the proposed extension of use it assessed. Prolonged high-temperature processing presents a different question from using a sweetener in a cold drink.

That distinction is easily lost in a headline. “Sucralose found safe” omits the uncertainty about the additional uses. “Heating sucralose definitely causes disease” goes beyond what the assessment establishes. To understand either claim, first identify the product, process and exposure being discussed.

Identifying sucralose on a label

Look for sucralose or E955 in the ingredient list. Imported Turkish packages may use the spellings sükraloz or sukraloz. The spelling alone does not identify a different sweetener. The complete ingredient list remains more informative than a front-of-pack sugar-replacement claim.

A drink, tablet or powder may contain additional sweeteners and other ingredients. Record each one separately rather than treating the preparation as pure sucralose. A statement about the substance does not automatically describe the complete nutritional composition of a commercial blend.

If its sucralose content is not disclosed, the total weight of the blend does not supply that missing amount. A teaspoon, a tablet and a scoop from different products are not common measures of sucralose exposure. Keep the manufacturer's serving definition with any comparison you make.

The two questions in EFSA's 2026 evaluation

EFSA's February 2026 announcement reports confirmation of the acceptable daily intake of 15 mg per kilogram of body weight per day for currently authorised uses. Its conclusion on additional uses in some fine bakery wares was different because of unresolved uncertainty.

This is an EFSA assessment, not a statement that every authority uses the same numerical value or that every jurisdiction has identical permissions. A scientific opinion also should not be presented as a complete, current list of national legal authorisations.

“Could not confirm the safety of additional uses” does not mean “all existing uses were banned.” Keep those statements separate when reading a report. Evaluating an established use in a finished food and evaluating a proposed industrial process are not the same task.

Why heating needs its own context

EFSA's plain-language summary discusses uncertainty about degradation products during domestic uses involving high temperatures. Time, temperature and the amount used can vary. Those variables should not disappear when the findings are translated into advice about a recipe.

The assessment does not justify inventing one universal temperature cutoff for every home kitchen. A condition used in an experiment is not automatically a precise safe-versus-unsafe boundary for all foods. Check the product's intended use and directions, and keep any unanswered questions visible.

Before buying, identify the use you have in mind: sweetening a drink or making something that will spend a long time in an oven? If asking a manufacturer for clarification, describe that use and the exact product. A broad marketing phrase such as suitable for everything does not explain the conditions investigated in a scientific assessment.

What an older rat study can tell us

The 2008 paper attached to sucralose in our catalogue investigated a Splenda preparation in male rats. It is not a clinical trial demonstrating that a particular retail product causes a named disease in humans. The tested preparation also should not automatically be equated with isolated sucralose.

Animal experiments can help investigate mechanisms and possible hazards. When moving from such a study to a claim about people, the species, formulation, dose and duration need to remain visible. Removing those details can make a paper appear to answer a question it did not test.

There is no need to erase the older study when describing the newer assessment. A better explanation identifies the evidence type and places it within the broader evaluation. Age alone does not determine whether a paper is informative, and a newer publication is not automatically a final answer.

A useful order for comparing products

Place the labels beside each other and fill in five fields:

1. Whether sucralose or E955 appears.
2. Other sweeteners and accompanying ingredients.
3. The stated serving size.
4. Whether nutrition values describe the product as sold or prepared.
5. The uses and directions described by the manufacturer.

Then write down what is missing. Do not estimate a sucralose quantity that the label does not disclose. If a powder contains maltodextrin, use our carbohydrate label guide to interpret that part of the formulation as well.

For example, one product might define a tablet as a serving and another might define a teaspoon of powder. Neither total package weight nor the number of servings establishes equivalent sucralose quantities. A calculation can look precise while relying on an unknown concentration, so establish that concentration before attempting a substance-level comparison.

Keep a label photo with the product variety and date of purchase. Manufacturers may change ingredients or instructions. If an online listing differs from your package, do not combine the serving information from one with the formulation from the other. Treat the discrepancy as a question to resolve.

Sources and scope

• Existing evidence record: the 2008 male-rat study.
• EFSA's announcement of its 2026 findings.
• EFSA: assessment summary and heating uncertainties.

This article explains how to read the evidence and a product label. It does not prescribe a personal intake. Check the current package for formulation and directions rather than transferring information from a different product or an older label.